Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0507, USA.
Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0622, USA.
Subst Abuse Treat Prev Policy. 2017 Oct 3;12(1):42. doi: 10.1186/s13011-017-0126-1.
Medication-assisted treatment (MAT) remains the gold standard for the treatment of opioid use disorder. MAT also reduces the frequency of injecting among people who inject drugs (PWID). Relatedly, data suggest that PWID play a key role in the initiation of others into drug injecting by exposing injecting practices to injection-naïve drug users. Our primary objective was to test whether a history of MAT enrollment is associated with a reduced odds of PWID providing injection initiation assistance.
Preventing Injecting by Modifying Existing Responses (PRIMER; NIDA DP2-DA040256-01), is a multi-site cohort study assessing the impact of socio-structural factors on the risk that PWID provide injection initiation assistance. Data were drawn from a participating cohort of PWID in San Diego, CA. The primary outcome was reporting ever providing injection initiation assistance; the primary predictor was reporting ever being enrolled in MAT. Logistic regression was used to model associations between MAT enrollment and ever initiating others into injecting while adjusting for potential confounders.
Participants (n = 354) were predominantly male (n = 249, 70%). Thirty-eight percent (n = 135) of participants reported ever initiating others into injection drug use. In multivariate analysis, participants who reported a history of MAT enrollment had significantly decreased odds of ever providing injection initiation assistance (Adjusted Odds Ratio [AOR]: 0.62, 95% Confidence Interval [CI]: 0.39-0.99).
These preliminary findings suggest an association between MAT enrollment and a lower odds that male PWID report providing injection initiation assistance to injection-naïve drug users. Further research is needed to identify the pathways by which MAT enrollment may impact the risk that PWID initiate others into drug injecting.
药物辅助治疗(MAT)仍然是治疗阿片类药物使用障碍的金标准。MAT 还减少了注射吸毒者(PWID)的注射频率。相关数据表明,PWID 通过向注射毒品的新手暴露注射实践,在他人开始注射毒品方面发挥着关键作用。我们的主要目标是检验 MAT 登记是否与 PWID 提供注射起始协助的可能性降低有关。
通过修改现有反应来预防注射(PRIMER;NIDA DP2-DA040256-01),这是一项多地点队列研究,评估社会结构因素对 PWID 提供注射起始协助的风险的影响。数据来自加利福尼亚州圣地亚哥的一个参与性 PWID 队列。主要结局是报告曾经提供过注射起始协助;主要预测因素是报告曾经接受过 MAT 登记。使用逻辑回归模型来对 MAT 登记与曾经启动他人注射之间的关联进行建模,同时调整潜在的混杂因素。
参与者(n=354)主要是男性(n=249,70%)。38%(n=135)的参与者报告曾经启动过他人注射毒品。在多变量分析中,报告有 MAT 登记史的参与者提供注射起始协助的可能性显著降低(调整后的优势比[OR]:0.62,95%置信区间[CI]:0.39-0.99)。
这些初步发现表明,MAT 登记与男性 PWID 报告向注射毒品的新手提供注射起始协助的可能性降低之间存在关联。需要进一步研究以确定 MAT 登记可能影响 PWID 开始他人吸毒的风险的途径。